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Long COVID-19: An emerging pandemic in itself
To the Editor
The novel coronavirus SARS-CoV-2 disease is 
predominantly a respiratory illness that is highly 
contagious and is spread by droplet transmission. 
It causes a spectrum of illnesses from a mild 
sore throat to serious viral pneumonia requiring 
hospitalisation [1]. It is estimated that about 80% 
of people infected with COVID-19 have a mild 
course of illness. About 20% of the remaining 
patients require hospitalisation to treat their 
pneumonia and may need therapeutic assistance 
with oxygen. In about 5% of cases, the pneumo-
nia becomes so severe that patients may need to 
be admitted to the intensive care unit for ven-
tilatory support [2]. Currently, the majority of 
attention has been focused on the management 
of critical cases. Patients who experience only 
mild symptoms are being managed on an outpa-
tient basis. However, it has become increasingly 
recognised that a sizeable third group of people 
seem to be demonstrating ongoing symptoms 
pertaining to COVID-19 far longer than expected 
for the disease pattern. This has raised concern 
amongst the health community due to the antici-
pated long-term effect on health care systems  [3].
Prevalence is unknown but not uncommon
“Long COVID” is a term being used to de-
scribe the long-term effects of COVID-19 in 
people who have had either suspected or con-
firmed COVID-19. These people are reporting 
lasting effects of the infection [4]. Data from the 
COVID-19 symptom tracker app developed by 
Kings College London/ZOE COVID Symptom 
Study estimates that up to 10% of people with 
COVID-19 take at least three weeks to recover 
with some experiencing symptoms for 30 days 
or more [5]. A team of researchers from Italy 
reported that nearly nine in 10 patients (87%) 
discharged from a Rome hospital after recovering 
from COVID-19 were still experiencing at least 
one symptom 60 days after onset [6]. 
Presentations are variable and non-specific
The characteristic symptoms of COVID-19 in-
clude fever, dry cough, and shortness of breath. 
Some people also experience aches and pains, 
a sore throat, and loss of taste and/or smell. Pa-
tients suffering from a mild form of the disease 
might expect to get better after a few weeks. There 
is growing evidence that, in some patients, the 
symptoms persist longer than expected. Besides 
the well-described symptoms of COVID-19, the 
British Lung Foundation and Asthma UK’s post-
COVID survey of over 1000 patients (of which 
over 800 had not been admitted to hospital) 
found that the top five reported symptoms of long 
COVID were breathing problems (90%), extreme 
tiredness (64%), sleeping problems (22%), cough 
(22%), and changes in mood involving anxiety 
or depression (22%) [7].  The majority of these 
people had not experienced these symptoms be-
fore COVID. The initial findings from the survey 
showed that many people who had a mild to mod-
erate course of disease are now on a long road to 
recovery that is affecting both their physical and 
mental health. The Italian study from Rome found 
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that, in patients recovering from COVID-19, many 
still reported fatigue (53%), dyspnoea (43%), joint 
pain (27%), and chest pain (22%) even though 
none of the patients had fever or any signs or 
symptoms of acute illness. Two-fifths of patients 
reported a worsened quality of life [6]. The re-
ported clinical features affect multiple parts of 
the body and are highlighted in Table 1.
An unknown pathophysiology that 
will be deciphered with time
As the understanding of COVID-19 is unrav-
elling, it has been acknowledged that COVID-19 is 
associated with inflammation and a prothrombot-
ic state [8]. People with severe COVID-19 seem 
to show an altered immune response and suffer 
an exaggerated inflammatory response (the “cy-
tokine storm”). Whether the triggering of the 
immune system has any role in the features of 
long COVID is unclear and hence, the exact un-
derlying pathophysiology of long COVID is still 
not known. It is evident that clinical features 
seen in this cohort of long COVID patients is not 
restricted to patients who had been hospitalized, 
but is also being observed in patients who have 
had an initial mild illness.
Huge impact in all dimensions of life
There is a growing body of evidence that 
a significant minority of patients are suffering 
from persisting and distressing symptoms that, 
under normal circumstances, would represent 
‘red-flag’ symptoms requiring urgent investiga-
tion. Many people report an emergence of new 
symptoms late in the course of their illness. They 
state that these symptoms exhibit a relapsing-re-
mitting pattern even though many had reported 
a mild initial illness. These factors combine to 
add to the distress and uncertainty of the con-
dition. The long-term effects of COVID-19, even 
on people who suffered a mild infection, could 
be far worse than were originally anticipated ac-
cording to researchers and doctors in Lombardy, 
Italy (the worst affected region in the country) [9]. 
The doctors warn that some victims may never 
recover from the illness and that all age groups 
are vulnerable. Some people may find that their 
ability to properly work, concentrate, and even 
take part in physical activities will be severely 
impaired. In the United Kingdom (UK), similar 
findings seem to have been found in a recent 
survey conducted by the British Lung Foundation 
and Asthma UK in people recovering from mild to 
moderate COVID-19. These patients had reported 
to have been struggling for weeks with symp-
toms, raising concerns that there is not adequate 
support for people who have not been treated on 
an inpatient basis with the illness [7]. The post-
COVID-19 period was also found to be taking its 
toll on patient’s mental health. Over one-half of 
the people surveyed said that they did not feel 
they can cope well after the illness. There have 
been some patients that have reported symptoms 
of post-traumatic stress disorder. 
Strategies
Recognising the growing concerns of patients, 
medical professionals, and medical organisations, 
the National Health Service (NHS) of England has 
launched a new service titled “Your COVID Re-
covery” in order to support, expand, and provide 
access to COVID-19 rehabilitation treatments for 
those who have survived the virus but still have 
problems with breathing, mental health, or other 
complications [11]. This post-COVID-19 support 
program idea can be extrapolated to support 
people in other countries. This support system 
consists of:
Multi-disciplinary support plans are being 
put into place to support patients who have been 
in hospitals or suffered at home with the virus 
with access to a face-to-face consultation with 
their local rehabilitation team (usually com-
prising of physiotherapists, nurses, and mental 





• Exacerbation of Asthma or COPD
• Persistent cough





Musculo-skeletal • Joint pain
• Myalgia
• Arthritis of small joints
Cardiovascular • Chest pain
• Palpitations
Neurological • Pins and needles’ sensation
• Headache
• Dizziness
COPD — chronic obstructive pulmonary disease; PTSD — post-traumatic 
stress disorder
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health specialists). The multi-disciplinary team 
will be able to assess the needs and provide an 
appropriate level of support.
Online Support: Peer-to-peer community 
and mental support groups have been developed 
(e.g. Long Covid.org) to provide online resources 
and exercise tutorials to help in the post-COVID 
recovery period. 
Social Media Support: Organisations and 
social media platforms (e.g. Facebook and Twitter) 
have created virtual support groups such as the 
“Long COVID Support group” for peer to peer 
support and information exchange. 
Future directions
As we learn more about COVID-19, dealing 
with the emerging problem of long COVID will 
require a coordinated response from the govern-
ment, public health bodies, healthcare systems, 
scientists, and the medical society in general. Re-
search into the long term effects of COVID-19 on 
both hospitalized patients and those who initially 
only had mild symptoms and were treated on 
an outpatient basis will be necessary to under-
stand and unravel the pathophysiology of long 
COVID. The Post-hospitalisation COVID-19 Study 
(PHOSP-COVID) that is being planned in order 
to assess the long-term effects of COVID-19 in 
hospitalized patients should be extended to in-
clude milder cases in order to understand the full 
spectrum of the disease [12].
Conclusion
It is important to acknowledge that the ef-
fects of COVID-19 are not only acute, but that 
the disease has long-term consequences as well. 
The recognition and increased awareness of long 
COVID is necessary to manage this illness effec-
tively. Rehabilitation, counselling, and mental 
health support form cornerstones of treating this 
condition. Establishing scientific studies and re-
search will help us to keep an open mind when 
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